Pharma anti counterfeiting 2012Document Transcript
Conference Hashtag - #VI_ACKey Speakers Include:-Ed Wheatley, Regional Investigations Director EMEA, Global Security, AstraZenecaWendy Greenall, Counterfeit Medicines Laboratory Manager – EMEA, PfizerTomasz Dzitko, CEO, DelfarmaUlrike Kreysa, Vice-President Healthcare, GS1 Global OfficeMonika Derecque-Pois, Director General, European Association ofPharmaceutical Full-Line Wholesalers (GIRP)Mustafa A. Zaman, Senior Consultant – Integrated Product Development (IPD), ParexelJim Thomson, Chair, European Alliance for Access to Safe Medicines (EAASM)Mark Davison, CEO, Blue Sphere HealthTanvi Goel, Global Serialization Manager, Mylan Pharmaceuticals-(EGA representative)Neil Lawrence, AIDC Programme Lead – Department of Health, NHSMaarten Van Baelen, Medical Affairs Manager, EGA (European Generic Medicines Association)Taha Yayci, Chief Executive Officer, TechNartsLisa Lovell, Managing Director & Anti-Counterfeiting, Brand EnforcementMarietta Ulrich-Horn, General Manager, SecurikettPlus Many More... Silver SponsorSupported By Organized By
Pharma Anti-Counterfeiting 2012 18th October 2012, London Marriott Marble Arch Hotel, London, UKCONFERENCE INTRODUCTION:-Counterfeit Pharmaceuticals do not only provoke immense economic damage to pharmaceutical companies but are a great risk to the public. The increasing threatcalls for immediate action against counterfeit medicines. Steps must be taken by governmental and international authorities as well as by every single affectedpharmaceutical company. Counterfeit APIs and medicines pose a growing threat to patients worldwide, with increasing numbers in Europe and the USA. Customs allover the world find more and more illegally produced drugs. Moreover, drugs are increasingly sold via the Internet making it much easier to put counterfeits intocirculation.Counterfeiting of drugs and medical devices cost the pharmaceutical and medical device industry billions of dollars annually in lost revenues. This loss is amplified bythe serious threats fake drugs pose to the health and safety of consumers. Directing your organization toward an successful brand protection system can be adaunting task given the sophistication of counterfeiters and the difficulty in tracking and prosecuting perpetrators. This in-depth workshop will teach you how toensure you have a solid counterfeit program and help you to gain a better understanding of how to develop an efficient brand protection program. It is estimatedthat counterfeiting is a $600 billion a year problem. In fact, it’s a problem that has grown over 10,000% in the past two decades, in part fuelled by CONSUMERDEMAND. The real truth is people who purchase counterfeit merchandise risk funding nefarious activities, contributing to unemployment, creating budget deficitsand compromising the future of this country in the global economy.The real truth is counterfeiters are hardened criminals, exploiting consumers, businesses both large and small, inventors and artists and children labouring insweatshops in Third World countries.The Facts:• Counterfeiting costs U.S. businesses $200 billion to $250 billion annually.• Counterfeit merchandise is directly responsible for the loss of more than 750,000 American jobs.• Since 1982, the global trade in illegitimate goods has increased from $5.5 billion to approximately $600 billion annually.• Approximately 5%-7% of the world trade is in counterfeit goods.• U.S. companies suffer $9 billion in trade losses due to international copyright piracy.• Counterfeiting poses a threat to global health and safety.This conference will gather government bodies, pharmaceutical companies and solution and technology providers to discuss the in-depth insights into the strategiesand cutting edge technologies for pharmaceutical anti-counterfeiting.It gives us immense pleasure in welcoming you to “Pharma Anti-Counterfeiting 2012 - Competences to Combat Counterfeits in EU & USA”KEY THEMES DISCUSSED AT THIS CONFERENCE:-• Anti-Counterfeiting and Product Security in EU and USA: government policies & strategies• Identifying current developments in counterfeits & ways to overcome threats• Discovering successful business models - Opportunities & Challenges• Identify main challenges and methods to improve Global Security• International partnerships and EU & U.S. regulations to combat counterfeit medicines• Practical Tips - Strategies for securing the supply chains of the 21st century - authentication, digital serialization, track and trace technologies and government enforcement• Best Practices on risk based approach to predict & prevent counterfeiting• Protect your products - Learn how to use the right packaging identification systems effectively• Discuss the impact of parallel trade and re-imports on counterfeiting medicines• Effective drug packaging design and technologies enhancing product efficiency, patient and health personnel security, compliance, ease of use• Establish robust pharmaceutical anti-counterfeiting and brand protection strategy to protect product and brand revenue• Involve the latest cutting edge serialisation & track & trace technologies for anti-counterfeiting• Include anti-counterfeiting in your business plan in order to secure product and supply chain safety in your company• How the FBI is currently addressing intellectual property crime and partnering with U.S. government agencies?• Network in our combined exhibition and catering area• Evening networking reception for all attendeesWHO WILL YOU MEET:-Brand Protection & Enforcement UnitsVPs, Heads, Directors and Managers with the following responsibilities:Anti-Counterfeiting Operations, Brand Protection, Brand Enforcement, Brand Security, Brand Integrity, Brand Management, Corporate Security, Global Security,Intellectual Property, Trademark ProtectionSupply ChainVPs, Heads, Directors and Managers with the following responsibilities:Supply Chain, Product Safety, Regulation & Quality, Quality Assurance, Track and Trace, Manufacturing Technologies, RFIDWHY SHOULD YOU ATTEND:-“Pharma Anti-Counterfeiting 2012 - Competences to Combat Counterfeits”Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networkingdrinks time, meet the leading companies showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business modelsand strategies in the high-level conference.
Pharma Anti-Counterfeiting 2012 18th October 2012, London Marriott Marble Arch Hotel, London, UK08:30 – Coffee and registration 11:30 – Eliminating the use of the Internet to purchase counterfeit products09:20 – Morning Chairs opening remarks The rise of the Internet has also facilitated the purchasing ofMark Davison, CEO, Blue Sphere Health counterfeit drugs. Over 50% of medicines purchased on the Internet(http://uk.linkedin.com/in/markdavison100) from illegal websites that conceal their physical addresses have been found to be counterfeit. However, counterfeit products increasingly find09:30 – Morning Keynote Address 1: Topic TBC their way into the legal supply chain10:00 – Morning Keynote Address 2 – "Case studies of • Authentication and traceability: complementary procedures forcounterfeit medicines entering the legitimate Supply Chain from the most effective strategyan AstraZeneca perspective” • Finding best ways to track down virtual phone sand email addresses• Specific AstraZeneca case studies involving counterfeit medicines • Implementing strategies to track down origination of counterfeiters and the supply chain• Examples from UK and across EMEA region 12:00 – Combating Counterfeits Online, a patient-led approach• How AZ manages the issue of “Supply Chain Integrity”• Key risks and how AZ mitigate them • Delivering the online elements of the FMD • Alerting the potential victimEd Wheatley, Regional Investigations Director EMEA, Global • Changing behaviourSecurity, AstraZeneca (http://uk.linkedin.com/pub/ed- • Communicating risk vs benefitwheatley/11/761/418) Jim Thomson, Chair, European Alliance for Access to Safe10:30 – Morning Keynote Panel Discussion: Challenges and Medicines (EAASM) (http://uk.linkedin.com/pub/jim-thomson/1b/47b/969)Opportunities 12:30 – The GS1 System and its relationship to AntiAs globalization has created more steps between production and Counterfeiting initiativesconsumption of pharmaceuticals, manufacturers have implementedvarious approaches to detect and prevent counterfeit products. A • Introducing GS1 and GS1 Healthcare; who they are, what they do,combination of anti-tamper, serialization and authentication current status, benefits and future trendstechnologies can be used to detect real versus counterfeit products, • Exploring GS1 Standards and their importance to the industrycreating several layers of security for original pharmaceutical • Identifying the relationship between GS1 Standards, Traceabilityproducers. and Anti-Counterfeiting initiatives• The Dark Side of Globalization: Conquering counterfeit medicine Ulrike Kreysa, Vice-President Healthcare, GS1 Global Office (http://be.linkedin.com/pub/ulrike-kreysa/1/23/13b) now requires a global solution• Advice to brand owners about how to coordinate/participate in government efforts• Internet Buying: Is it so Dangerous? How to make it safer and thus 13:00 - Networking luncheon - Take your discussions bring the benefits of Internet prices to all. further & build new relationships in a relaxed• Identifying the scope of the problem of counterfeit medicines and & informal setting... medical devicesModerator –Mark Davison, CEO, Blue Sphere Health(http://uk.linkedin.com/in/markdavison100)Panelists –Mustafa A. Zaman, Senior Consultant – Integrated ProductDevelopment (IPD), Parexel(http://uk.linkedin.com/pub/mustafa-a-zaman/3/a30/721)Neil Lawrence, AIDC Programme Lead – Department ofHealth, NHS (http://uk.linkedin.com/pub/neil-lawrence/4/986/24b)Taha Yayci, Chief Executive Officer, TechNarts(http://tr.linkedin.com/in/tahayayci)11:10 – Morning Coffee & Networking
Pharma Anti-Counterfeiting 2012 18th October 2012, London Marriott Marble Arch Hotel, London, UK14:00 – Afternoon Keynote Panel Discussion: A complete 16:10 – Panel Discussion: Recent legislative and regulatorymethodology to brand protection – manufacturers developmentsstandpoint Pharmaceutical manufacturers, industry suppliers and governments• Securing the pharmaceutical supply chain – tactics and have been uniting to combat counterfeit drugs. While international compliance regulations and guidelines have been developed to help accomplish• Finding the “business case” for state, federal, regulatory this, regional and local regulations vary at present. To address this requirements issue new EU Serialization will be introduced in 2014 followed by• Building an internal product safety & security team the new FDA/California Serialization standard in 2015. Both of• Developing A robust yet flexible anti-counterfeiting strategy for these initiatives aim to harmonize coding and require manufacturer The modern age To ensure patient safety & reduce Ipr to implement serialization systems. enforcement costs• Practical advice for anti-counterfeiting and brand protection • Analysing legal procedures after finding counterfeit drugs• 2015 readiness assessment – how to ensure preparedness – • Insight into initiatives to promote a global anti-counterfeiting pitfalls to avoid law • What governments expect from brand holders when addressingModerator: IP cases • How businesses can partner with EU & US customs and borderMark Davison, CEO, Blue Sphere Health protection to protect their rights(http://uk.linkedin.com/in/markdavison100) • Collaboration & Interaction between stakeholders & law enforcement - Building an interactive network with governmentPanelists: & police for investigating & to monitor, track, trace counterfeiting drugsTomasz Dzitko, CEO, Delfarma(http://pl.linkedin.com/pub/tomasz-dzitko/11/24a/762) • How the FBI is currently addressing counterfeit products and IP crimeWendy Greenall, Counterfeit Medicines Laboratory Manager– EMEA, Pfizer (http://uk.linkedin.com/pub/wendy-greenall/15/5a3/619) Moderator:Tanvi Goel, Global Serialization Manager, Mylan Mark Davison, CEO, Blue Sphere HealthPharmaceuticals-(EGA representative) (http://uk.linkedin.com/in/markdavison100)(http://ie.linkedin.com/pub/tanvi-goel/15/6b2/692) Panelists:Lisa Lovell, Managing Director & Anti-Counterfeiting, BrandEnforcement (http://uk.linkedin.com/in/lisalovell) Monika Derecque-Pois, Director General, European Association of Pharmaceutical Full-Line Wholesalers (GIRP)Marietta Ulrich-Horn, General Manager, Securikett (http://be.linkedin.com/pub/monika-derecque-pois/8/b26/7aa)(http://at.linkedin.com/pub/marietta-ulrich-horn/0/679/a9a) Maarten Van Baelen, Medical Affairs Manager, EGA (European Generic Medicines Association) (http://be.linkedin.com/pub/maarten-van-baelen/4/200/544)14:50 – European Medicines Verification system and the GoodDistribution Practice guideline revision• Modalities of medicines verifications• System structure and governance 16:50 – Chairpersons closing remarks and end of conference• Country requirements: Interoperability and system integration• Challenges and economic impact of proposed new GDP guidelines on wholesale distributors 17:00 - 18:00 - Networking Drinks - Take your discussions further & build new relationships in a relaxedMonika Derecque-Pois, Director General, European Association & informal setting...of Pharmaceutical Full-Line Wholesalers (GIRP)(http://be.linkedin.com/pub/monika-derecque-pois/8/b26/7aa)15:20 – Afternoon coffee & Networking15:40 – Initiatives of Parallel Distributors in the context ofFalsified Medicines Directive• Good Parallel Distribution Guidelines• Early Warning Anti-Counterfeit Platform• Joint Audits Initiative• Collaboration with other stakeholdersTomasz Dzitko, CEO, Delfarma(http://pl.linkedin.com/pub/tomasz-dzitko/11/24a/762)
Pharma Anti-Counterfeiting 2012 18th October 2012, London Marriott Marble Arch Hotel, London, UK REGISTRATION:-For Multiple Bookings - Photocopy this form...DELEGATE DETAILS:Title Mr Mrs Ms Miss DrFirst Name SurnamePosition CompanyAddress Postcode FaxTelephone EmailRESERVATION PRICING:Early Booking (ends 18th July) - £350 + VAT per delegateStandard Pricing - £500 + VAT per delegateGroup Booking (2 and more delegates) - £400 + VAT per delegatePAYMENT:Please send me a VAT invoice Our purchase order no.isI enclose a cheque for £ Payable to Virtue Insight LtdPlease charge my card £ Card type: Visa Mastercard Maestro AmexCard NumberSecurity NoIssue Date / Expiry Date /Cardholder’s NameCardholder’s Registered Address Postcode DateSignatureFOR BANK TRANSFER:Account Name - Virtue Insight LTD Account Number - 62318474 Bank Name - HSBC Sort Code - 40-25-27TERMS AND CONDITIONS:Payment terms:Virtue Insight requires the full amount to be paid before the conference. Virtue Insight may refuse entry to delegates who have not paid their invoice in full.Substitutions/name changes or cancellations:There is a 50% liability on all bookings once made, whether by post, fax, or email. There is a no refund policy for cancellations received on or after one month beforethe start of the event. Should you decide to cancel after this date, the full invoice must be paid. Conference notes will then be sent to you. Unfortunately, we are unableto transfer places between conferences and executive briefings. However, if you cannot attend the conference, you may make a substitution/name change at any time, aslong as we are informed in writing by email, fax or post. Name changes and substitutions must be from the same company or organization and are not transferablebetween countries.Indemnity:Virtue Insight reserves the right to make alterations to the conference/executive briefing content, timing, speakers or venue without notice. The event may be postponedor cancelled due to unforeseen events beyond the control of Virtue Insight. If such a situation arises, we will refund your registration fee and we will try to reschedule theevent.Fee:The conference fee includes lunch, refreshments and conference papers provided on the day. This fee does not include travel or hotel accommodation.How we will contact you:Virtue Insights preferred method of communication is by email and phone. Please ensure that you complete the registration form in full so that we can contact you.